The rare disease challenge
Natalie Douglas looks at the ongoing needs and challenges for rare disease patients and their care moving forward
27th February 2020
Web Exclusives
The promise of IoMT
How the Internet of Medical Things (IoMT) can streamline clinical ops – and why it’s worth the investment
25th February 2020
How tech advancements are impacting cancer research
Giving cancer research the best chance of success
13th February 2020
Treating a label like a machine Is transformational
The pharmaceutical industry has a head-start on heavyweight compliance and legacy product transparency requirements but do medical device manufacturers bring new advantage from an engineering mindset?
13th February 2020
The fork in the road
Gilead's Hilary Hutton-Squire on industry, innovation, and the NICE Methods Review
6th February 2020
The dangers of reduced market choice in life sciences
Industry consolidation continues apace, harming competition and reducing choice. Alan White warns that customers now need to be more discerning when assessing suppliers’ relative value.
4th February 2020
World Cancer Day exclusive: Putting the ‘personal’ into personalised medicine
Geoff Twist, managing director for Roche Diagnostics UK and Ireland, on working towards cancer treatment that's fit for the future
4th February 2020
World Cancer Day: interview with Janssen's Biljana Naumovic
To mark World Cancer Day, PharmaTimes talks to Janssen's Biljana Naumovic about the current landscape in oncology
4th February 2020
Putting the EMA medicines database to effective use
Momentum and vision around IDMP must be maintained in 2020 if standardised medicinal product data is to be of tangible real-world benefit
3rd February 2020
Upskilling sales reps in a data-driven world
Why companies need to upskill sales reps so they can thrive in this new data-driven world
30th January 2020
A smart future
How artificial intelligence (AI) is changing the pharma and biotech industries
23rd January 2020
